title: Superior vena caval resection in lung cancer.
abstract: Lung cancer with involvement of the SVC is uncommon but presents a unique management challenge. Discovery of N2 disease should be given its due diligence and these patients should undergo induction therapy. Patients can attain favorable long-term outcomes with surgery, but they need to be carefully selected at specialized centers.
authors.affiliation: Department of Thoracic Surgery, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1023, New York, NY 10029, USA. Electronic address: dong-seok.lee@mountsinai.org.
authors.forename: Dong-Seok D
authors.initials: DS
authors.lastname: Lee
authors.affiliation: Department of Thoracic Surgery, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1023, New York, NY 10029, USA.
authors.forename: Raja M
authors.initials: RM
authors.lastname: Flores
mesh_terms: D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery*; D019043:Vascular Neoplasms / Q000556:secondary / Q000601:surgery*; D014656:Vascular Surgical Procedures / Q000379:methods*; D014683:Vena Cava, Superior / Q000601:surgery*
keywords: Caval invasion; Caval reconstruction; Caval resection; Lung cancer; Superior vena cava